Ortho Clinical Diagnostics Holdings PLC Stock News

RARITAN, N.J., July 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play, in-vitro diagnostics (IVD) companies, today announced its distribution a

- Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test - Both new antibody tests help health care teams differentiate the cause of

RARITAN, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that members of it

Ortho Clinical Diagnostics Holdings plc (OCDX) CEO Chris Smith on Q1 2021 Results - Earnings Call Transcript

First Quarter Revenue Growth Exceeds Company's Expectations at 24.2%, Supporting Increase in 2021 Guidance First Quarter Revenue Growth Exceeds Company's Expectations at 24.2%, Supporting Increase in

ORTHO VISION is the leading choice for blood banks RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics c

RARITAN, N.J., April 26, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, has been recognized with a presti

RARITAN, N.J., April 13, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received CE Marking

- The new contract will deliver Ortho with funding for capacity expansion to provide up to 6.7 million COVID-19 tests per month dedicated for the U.S. market over the next 12-14 months  RARITAN, N.J.

Fourth Quarter Revenue Growth Ahead of Company Expectations at 9.1% Fourth Quarter Revenue Growth Ahead of Company Expectations at 9.1%

Fourth Quarter Revenue Growth Ahead of Company Expectations at 9.1% Fourth Quarter Revenue Growth Ahead of Company Expectations at 9.1%

RARITAN, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies dedicated to transfo

Former CEO of Charles Schwab Investment Management will also serve as audit committee chair Former CEO of Charles Schwab Investment Management will also serve as audit committee chair

Agencies Provide Stable Outlook Following Company's Initial Public Offering Agencies Provide Stable Outlook Following Company's Initial Public Offering

Increases facility by $150 million and extends it to 2026